US Broker Ratings

Integer Holdings Corporation (ITGR): Analyst Consensus Signals Significant Growth Potential with a 36% Upside

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, specializes in the development and manufacturing of medical devices. With a market capitalization of $3.62 billion, Integer operates..

Avidity Biosciences, Inc. (RNA) Stock Analysis: 66% Upside Potential Draws Investor Attention

Avidity Biosciences, Inc. (NASDAQ: RNA) has emerged as a compelling player in the biotechnology sector, capturing investor interest with its innovative approach to RNA therapeutics. Specializing in antibody oligonucleotide conjugates..

Insmed Incorporated (INSM) Stock Analysis: Exploring a 9.92% Potential Upside in the Biotech Arena

In the rapidly evolving world of biotechnology, Insmed Incorporated (NASDAQ: INSM) stands out as a significant player with a promising pipeline targeting rare diseases. As of the latest data, the..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: A 70% Potential Upside Awaits Investors

Investors with a keen eye on the biotech sector might want to take a closer look at Akero Therapeutics, Inc. (NASDAQ: AKRO), a company that has been making waves in..

STERIS plc (STE) Stock Analysis: Navigating a Promising Upside with 9.5% Potential for Investors

For investors eyeing opportunities in the healthcare sector, STERIS plc (NYSE: STE) stands out as a noteworthy contender. With a market capitalization of $24.5 billion, STERIS operates in the medical..

Waystar Holding Corp. (WAY): Investor Outlook with a 31.75% Potential Upside

Waystar Holding Corp. (NASDAQ: WAY) is capturing attention in the healthcare sector with its innovative cloud-based software solutions for healthcare payments. As healthcare providers increasingly seek efficiency in financial operations,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Landscape with a 41% Potential Downside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare technology sector, is facing a complex financial landscape that requires careful navigation by investors. With a market capitalization of..

Verona Pharma plc (VRNA): Investor Outlook and Analyst Consensus on a Biotech Powerhouse

Verona Pharma plc (NASDAQ: VRNA), a burgeoning player in the biotechnology sector, has captured investor attention with its strategic focus on respiratory therapies. Headquartered in London, this UK-based biopharmaceutical company..

Koninklijke Philips N.V. (PHG) Stock Analysis: Healthcare Giant with a 16.65% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, operates within the medical devices industry. With a market capitalization of $26.88 billion, this Dutch multinational is a significant..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 15.44% Upside Potential Amidst Challenging Metrics

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, stands at an intriguing juncture for investors. The company, with a market capitalization of $11.54 billion, operates across a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Powerhouse with 26% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a formidable player in the biotechnology sector, with a compelling narrative that has captured the attention of investors. With a market capitalization of..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A High-Valuation Biotech with Strong Analyst Confidence

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in RNA interference (RNAi) therapeutics, stands out in the biotechnology sector with a significant market capitalization of $59.45 billion. Based in Cambridge, Massachusetts,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Navigating the Potential Upside in a Volatile Market

Investors have their eyes on iRhythm Technologies, Inc. (NASDAQ: IRTC), a standout player in the healthcare sector, particularly in the medical devices industry. Known for its pioneering work in ambulatory..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a Potential 52.51% Upside in the CNS Therapeutics Market

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, is making waves in the biotechnology sector with its promising pipeline and robust..

AstraZeneca PLC (AZN): Investor Outlook with a 14.54% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (AZN) stands prominently as a global leader in the healthcare sector, with a particular focus on the discovery, development, and commercialization of prescription medicines. With a market capitalization..

DexCom, Inc. (DXCM) Stock Analysis: A 51% Upside Potential and Strong Buy Consensus

For investors seeking promising opportunities in the healthcare sector, DexCom, Inc. (NASDAQ: DXCM) presents a compelling case. As a leading player in the medical devices industry, DexCom specializes in continuous..

Insulet Corporation (PODD) Stock Analysis: A 32.9% Revenue Growth Powerhouse with Robust Buy Ratings

Insulet Corporation (NASDAQ: PODD) continues to make waves in the healthcare sector, specifically within the medical devices industry, with its innovative insulin delivery systems. The company, headquartered in Acton, Massachusetts,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: A Biotech Star with 120% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning Australian biotechnology company, is increasingly capturing the attention of investors with its impressive growth trajectory and promising product pipeline. Specializing in the development..

Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Amidst Mixed Ratings

Elanco Animal Health Incorporated (NYSE: ELAN), a prominent player in the healthcare sector, continues to assert its influence in the drug manufacturing industry, specializing in both specialty and generic products..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Healthcare Potential with an 8.15% Upside

Teleflex Incorporated (NYSE: TFX) stands as a significant player in the healthcare sector, specializing in the design and production of single-use medical devices essential for critical care and surgical applications...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds